|
|
Pathogenesis
Cell-mediated Protection in
Influenza Infection
Paul G. Thomas,* Rachael Keating,* Diane J. Hulse-Post,* and Peter
C. Doherty*
*St. Jude Children's Research Hospital, Memphis, Tennessee, USA
Suggested
citation for this article
Appendix
Bibliography
- Arnold PY, Vignali KM, Miller TB, La Gruta NL, Cauley
LS, Haynes L, et al. Reliable
generation and use of MHC class II:gamma2aFc multimers for the identification
of antigen-specific CD4(+) T cells. J Immunol Methods. 2002;271:137–51.
- Belz GT, Xie W, Doherty PC. Diversity
of epitope and cytokine profiles for primary and secondary influenza
a virus-specific CD8+ T cell responses. J Immunol. 2001;166:4627–33.
- Boon AC, de Mutsert G, Fouchier RA, Sintnicolaas K, Osterhaus AD,
Rimmelzwaan GF. Preferential
HLA usage in the influenza virus-specific CTL response. J Immunol.
2004;172:4435–43.
- Cerwenka A, Morgan TM, Harmsen AG, Dutton RW. Migration
kinetics and final destination of type 1 and type 2 CD8 effector cells
predict protection against pulmonary virus infection. J Exp Med.
1999;189:423–34.
- Chen W, Bennink JR, Morton PA, Yewdell JW. Mice
deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain
the typical immunodominance hierarchies of CD8+ T-cell responses to
influenza virus. J Virol. 2002;76:10332–7.
- Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG.
Effector
CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus
infections. Immunol Rev. 1997;159:105–17.
- Falk K, Rotzschke O, Deres K, Metzger J, Jung G, Rammensee HG. Identification
of naturally processed viral nonapeptides allows their quantification
in infected cells and suggests an allele-specific T cell epitope forecast.
J Exp Med. 1991;174:425–34.
- Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. Virus-specific
CD8+ T cells in primary and secondary influenza pneumonia. Immunity.
1998;8:683–91.
- Flynn KJ, Riberdy JM, Christensen JP, Altman JD, Doherty PC. In
vivo proliferation of naive and memory influenza-specific CD8(+) T cells.
Proc Natl Acad Sci U S A. 1999;96:8597–602.
- Hou S, Hyland L, Ryan KW, Portner A, Doherty PC. Virus-specific
CD8+ T-cell memory determined by clonal burst size. Nature. 1994;369:652–4.
- Hu N, D'Souza C, Cheung H, Lang H, Cheuk E, Chamberlain
JW. Highly
conserved pattern of recognition of influenza A wild-type and variant
CD8(+) CTL epitopes in HLA-A2(+) humans and transgenic HLA-A2(+)/H2
class I-deficient mice. Vaccine. 2005;23:5231–44.
- Kilbourne ED. Future
influenza vaccines and the use of genetic recombinants. Bull World
Health Organ. 1969;41:643–5.
- Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication.
In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP,
et al., editors. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven
Publishers; 1996. 1353–95.
- Lawson CM, Bennink JR, Restifo NP, Yewdell JW, Murphy BR. Primary
pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia
virus recombinant expressing influenza A virus nucleoprotein peptide
do not protect mice against challenge. J Virol. 1994;68:3505–11.
- Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al.
Recognition
of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl
Acad Sci U S A. 2004;101:5598–603.
- Rott R, Klenk HD, Nagai Y, Tashiro M. Influenza
viruses, cell enzymes, and pathogenicity. Am J Respir Crit Care
Med. 1995;152:S16–9.
- Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM. Confronting
the avian influenza threat: vaccine development for a potential pandemic.
Lancet Infect Dis. 2004;4:499–509.
- Topham DJ, Doherty PC. Clearance
of an influenza A virus by CD4+ T cells is inefficient in the absence
of B cells. J Virol. 1998;72:882–5.
- Wood JM, Robertson JS. From
lethal virus to life-saving vaccine: developing inactivated vaccines
for pandemic influenza. Nat Rev Microbiol. 2004;2:842–7.
- Wraith DC, Vessey AE, Askonas BA. Purified
influenza virus nucleoprotein protects mice from lethal infection.
J Gen Virol. 1987;68:433–40.
- Zaunders JJ, Dyer WB, Wang B, Munier ML, Miranda-Saksena
M, Newton R, et al.
Identification of circulating antigen-specific CD4+ T lymphocytes with
a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and
in CMV infection. Blood. 2004;103:2238–47.
Suggested citation
for this article:
Thomas PG, Keating
R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection.
Emerg Infect Dis [serial on the Internet]. 2006 Jan [date cited].
Available from http://www.cdc.gov/ncidod/EID/vol12no01/05-1237.htm
|
